Jeffrey A Mann, MD
Orthopedic Surgery · Oakland
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Offices
- 7
On the public record
- Owns East Bay Special Surgery, LLC: Accreditation Lapsed
Offices
7 locations · Sutter Bay Medical Foundation · California Sports and Orthopaedic
Looking this up.
Hospitals listed: 057004 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mann’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G72983 · Current
Licensed to practise in California · since 1991 · expires 2027-10-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- East Bay Special Surgery, LLCAmbulatory Surgery Center · Oakland, CA7.66% owner since 2015 · accredited by IMQAccreditation Lapsed1 inspection, 1 with deficiencies · last 2015-11-19: Requirements Met
- The Surgery Center of Alta Bates Summit Medical CenterAmbulatory Surgery Center · Oakland, CAOwner · accredited by JCInitial Accreditation4 inspections, 4 with deficiencies · last 2017-07-27: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$134,279
Medicare paid this office $134,279 for 413 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 239 | $31,472 | $80 |
| New patient visit (30+ min) | 117 | $10,946 | $94 |
| Return visit (30+ min) | 74 | $8,931 | $112 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 31 | $8,027 | $108 |
| New patient visit (45+ min) | 50 | $7,319 | $146 |
See all 16 services
| Short return visit (20+ min) | 239 | $31,472 | $80 |
| New patient visit (30+ min) | 117 | $10,946 | $94 |
| Return visit (30+ min) | 74 | $8,931 | $112 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 31 | $8,027 | $108 |
| New patient visit (45+ min) | 50 | $7,319 | $146 |
| X-ray of ankle, minimum of 3 views | 96 | $6,613 | $38 |
| X-ray of foot, minimum of 3 views | 123 | $5,923 | $33 |
| Complete ultrasound scan of joint | 74 | $3,691 | $47 |
| Harvest of graft from large bone | 11 | $1,348 | $123 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 12 | $1,197 | $85 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 11 | $1,043 | $74 |
| Short return visit | 15 | $899 | $50 |
| X-ray of knee, 1-2 views | 17 | $755 | $31 |
| X-ray of knee, 3 views | 18 | $701 | $39 |
| X-ray of foot, 2 views | 13 | $510 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 36 | $191 | None |
Procedures Medicare counted
| Knee replacement | 12 | More than 39% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
413 Original Medicare patients in 2024. Average age 74 · Women 62% · Also on Medicaid 4% · Health risk score 0.82. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 54% · Coronary heart disease 17% · Diabetes 15% · Chronic kidney disease 15% · Depression 15% · Cancer 14% · Atrial fibrillation 11% · Heart failure 6% · COPD 5% · Stroke 5%.
The office billed $410,030, Medicare allowed $179,056 and paid $134,279; for 10,499 services of 69 kinds; $6,839 of it was for drugs given in the office and $127,440 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 413 | 10,499 | 74 | 0.82 | $410,030 | $134,279 |
| 2023 | 436 | 6,080 | 73 | 0.87 | $455,470 | $145,322 |
| 2022 | 366 | 2,542 | 73 | 0.86 | $350,716 | $115,088 |
| 2021 | 357 | 1,677 | 73 | 0.87 | $338,086 | $113,110 |
| 2020 | 329 | 1,036 | 72 | 0.86 | $290,219 | $91,002 |
| 2019 | 349 | 1,255 | 72 | 0.90 | $317,558 | $98,419 |
| 2018 | 414 | 1,535 | 71 | 1.00 | $369,861 | $113,894 |
| 2017 | 373 | 1,545 | 70 | 1.00 | $396,634 | $121,628 |
| 2016 | 360 | 1,576 | 72 | 1.03 | $367,876 | $111,798 |
| 2015 | 377 | 1,772 | 71 | 1.04 | $406,047 | $113,105 |
| 2014 | 323 | 1,566 | 71 | 0.97 | $396,189 | $108,422 |
| 2013 | 270 | 1,390 | 71 | 1.10 | $263,452 | $91,781 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Short return visit (20+ min) | 267 | $30,934 | $76 |
| New patient visit (30+ min) | 130 | $12,442 | $96 |
| Return visit (30+ min) | 56 | $6,862 | $109 |
| New patient visit (45+ min) | 48 | $6,160 | $128 |
| X-ray of foot, minimum of 3 views | 103 | $6,112 | $34 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 25 | $5,315 | $98 |
| X-ray of ankle, minimum of 3 views | 85 | $4,926 | $37 |
| Complete ultrasound scan of joint | 63 | $3,377 | $50 |
| Removal of deep implant from bone | 11 | $2,664 | $242 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 17 | $1,692 | $81 |
| Short return visit | 30 | $1,664 | $49 |
| X-ray of knee, 1-2 views | 20 | $933 | $33 |
| X-ray of knee, 3 views | 21 | $830 | $38 |
| X-ray of foot, 2 views | 17 | $791 | $27 |
| X-ray of ankle, 2 views | 13 | $511 | $34 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $489 | $35 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 11 | $315 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $189 | None |
2022: 14 services
| Short return visit (20+ min) | 191 | $22,230 | $79 |
| New patient visit (30+ min) | 121 | $10,597 | $88 |
| Return visit (30+ min) | 61 | $7,366 | $107 |
| New patient visit (45+ min) | 48 | $6,482 | $135 |
| X-ray of ankle, minimum of 3 views | 93 | $5,834 | $36 |
| X-ray of foot, minimum of 3 views | 81 | $3,603 | $33 |
| Complete ultrasound scan of joint | 51 | $2,822 | $55 |
| Short return visit | 47 | $2,670 | $49 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $1,798 | $95 |
| X-ray of knee, 3 views | 19 | $844 | $40 |
| X-ray of foot, 2 views | 20 | $779 | $24 |
| X-ray of knee, 1-2 views | 15 | $570 | $28 |
| X-ray of ankle, 2 views | 11 | $404 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $151 | None |
2021: 15 services
| Short return visit (20+ min) | 190 | $21,288 | $82 |
| New patient visit (30+ min) | 115 | $10,362 | $90 |
| New patient visit (45+ min) | 56 | $7,956 | $142 |
| Return visit (30+ min) | 43 | $5,500 | $115 |
| X-ray of ankle, minimum of 3 views | 61 | $3,290 | $36 |
| X-ray of foot, minimum of 3 views | 48 | $2,524 | $35 |
| Complete ultrasound scan of joint | 37 | $2,416 | $64 |
| Short return visit | 36 | $2,165 | $50 |
| Harvest of graft from large bone | 11 | $1,380 | $125 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 11 | $1,363 | $85 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 12 | $742 | $53 |
| X-ray of foot, 2 views | 15 | $613 | $28 |
| X-ray of knee, 1-2 views | 11 | $568 | $35 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $380 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $114 | None |
2020: 12 services
| Short return visit (20+ min) | 193 | $17,561 | $61 |
| New patient visit (30+ min) | 122 | $10,900 | $89 |
| X-ray of ankle, minimum of 3 views | 65 | $3,315 | $32 |
| New patient visit (45+ min) | 27 | $3,305 | $122 |
| Complete ultrasound scan of joint | 31 | $2,433 | $74 |
| X-ray of foot, minimum of 3 views | 57 | $2,156 | $28 |
| Return visit (30+ min) | 19 | $1,925 | $96 |
| Short return visit | 39 | $1,794 | $41 |
| Harvest of graft from large bone | 12 | $1,687 | $130 |
| X-ray of foot, 2 views | 12 | $483 | $27 |
| X-ray of ankle, 2 views | 12 | $403 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $94 | None |
2019: 11 services
| Short return visit (20+ min) | 196 | $17,636 | $60 |
| New patient visit (30+ min) | 138 | $11,840 | $86 |
| X-ray of ankle, minimum of 3 views | 83 | $4,381 | $31 |
| New patient visit (45+ min) | 30 | $3,761 | $125 |
| Return visit (30+ min) | 36 | $3,657 | $91 |
| Complete ultrasound scan of joint | 40 | $3,490 | $83 |
| Harvest of graft from large bone | 16 | $2,272 | $126 |
| X-ray of foot, minimum of 3 views | 45 | $1,757 | $27 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 17 | $1,682 | $76 |
| X-ray of foot, 2 views | 23 | $965 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $212 | None |
2018: 17 services
| Short return visit (20+ min) | 249 | $22,937 | $61 |
| New patient visit (30+ min) | 200 | $16,736 | $84 |
| Reconstruction of ankle joint with prosthesis | 12 | $10,000 | $833 |
| X-ray of ankle, minimum of 3 views | 81 | $3,685 | $28 |
| New patient visit (45+ min) | 24 | $3,440 | $143 |
| Complete ultrasound scan of joint | 31 | $3,438 | $98 |
| X-ray of foot, minimum of 3 views | 89 | $3,379 | $25 |
| Harvest of graft from large bone | 15 | $1,883 | $126 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 18 | $1,488 | $74 |
| Return visit (30+ min) | 12 | $968 | $81 |
| Application of short leg cast | 11 | $893 | $69 |
| X-ray of ankle, 2 views | 25 | $810 | $28 |
| X-ray of knee, 1-2 views | 25 | $735 | $27 |
| X-ray of foot, 2 views | 21 | $709 | $24 |
| X-ray of both knees while standing | 15 | $474 | $32 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $390 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $354 | None |
2017: 17 services
| Short return visit (20+ min) | 219 | $21,529 | $61 |
| New patient visit (30+ min) | 212 | $17,565 | $83 |
| Reconstruction of ankle joint with prosthesis | 15 | $13,603 | $850 |
| X-ray of ankle, minimum of 3 views | 91 | $4,445 | $29 |
| X-ray of foot, minimum of 3 views | 83 | $3,987 | $27 |
| Complete ultrasound scan of joint | 24 | $2,638 | $110 |
| Harvest of graft from large bone | 16 | $1,999 | $125 |
| Application of short leg cast | 14 | $1,130 | $75 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,105 | $46 |
| X-ray of knee, 1-2 views | 27 | $964 | $28 |
| X-ray of foot, 2 views | 30 | $908 | $23 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $887 | $74 |
| X-ray of ankle, 2 views | 19 | $669 | $29 |
| X-ray of both knees while standing | 17 | $564 | $33 |
| Short return visit | 12 | $489 | $41 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $386 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 44 | $311 | None |
2016: 16 services
| Short return visit (20+ min) | 196 | $18,179 | $56 |
| New patient visit (30+ min) | 218 | $17,775 | $82 |
| Reconstruction of ankle joint with prosthesis | 11 | $8,929 | $812 |
| X-ray of ankle, minimum of 3 views | 95 | $3,960 | $26 |
| X-ray of foot, minimum of 3 views | 79 | $3,157 | $23 |
| Harvest of graft from large bone | 19 | $2,488 | $118 |
| Complete ultrasound scan of joint | 22 | $2,396 | $104 |
| Application of short leg cast | 19 | $1,525 | $69 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,346 | $54 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 15 | $1,037 | $65 |
| X-ray of both knees while standing | 28 | $915 | $33 |
| X-ray of knee, 1-2 views | 27 | $866 | $26 |
| X-ray of foot, 2 views | 24 | $719 | $22 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 19 | $675 | $31 |
| X-ray of ankle, 2 views | 12 | $370 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | $295 | None |
2015: 15 services
| Short return visit (20+ min) | 207 | $19,683 | $57 |
| New patient visit (30+ min) | 206 | $17,246 | $84 |
| X-ray of foot, minimum of 3 views | 87 | $3,500 | $24 |
| X-ray of ankle, minimum of 3 views | 75 | $3,345 | $27 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,804 | $165 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $1,952 | $89 |
| Harvest of graft from large bone | 11 | $1,344 | $122 |
| Application of short leg cast | 17 | $1,268 | $75 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 15 | $1,091 | $68 |
| X-ray of knee, 1-2 views | 30 | $1,066 | $26 |
| X-ray of foot, 2 views | 26 | $980 | $21 |
| X-ray of both knees while standing | 26 | $681 | $26 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 16 | $513 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $314 | None |
| X-ray of ankle, 2 views | 12 | $302 | $23 |
2014: 15 services
| Short return visit (20+ min) | 172 | $16,127 | $59 |
| New patient visit (30+ min) | 188 | $15,045 | $80 |
| X-ray of ankle, minimum of 3 views | 82 | $4,220 | $31 |
| Ultrasonic guidance for needle placement | 35 | $3,531 | $67 |
| X-ray of foot, minimum of 3 views | 49 | $2,735 | $28 |
| Aspiration and/or injection of fluid from large joint | 24 | $2,106 | $57 |
| Complete ultrasound scan of joint | 16 | $1,800 | $112 |
| Harvest of graft from large bone | 11 | $1,481 | $123 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,296 | $108 |
| Application of short leg cast | 12 | $976 | $75 |
| X-ray of foot, 2 views | 24 | $944 | $26 |
| X-ray of knee, 1-2 views | 23 | $765 | $26 |
| X-ray of both knees while standing | 23 | $709 | $31 |
| Short return visit | 13 | $446 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 36 | $327 | None |
2013: 15 services
| Short return visit (20+ min) | 145 | $14,854 | $60 |
| New patient visit (30+ min) | 127 | $11,028 | $87 |
| Ultrasonic guidance for needle placement | 28 | $7,245 | $201 |
| X-ray of ankle, minimum of 3 views | 68 | $3,773 | $31 |
| X-ray of foot, minimum of 3 views | 66 | $3,584 | $30 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,993 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,610 | $115 |
| Short return visit | 25 | $1,121 | $36 |
| Application of short leg cast | 12 | $996 | $77 |
| X-ray of knee, 1-2 views | 22 | $982 | $30 |
| X-ray of foot, 2 views | 21 | $811 | $26 |
| X-ray of ankle, 2 views | 14 | $424 | $27 |
| X-ray of both knees while standing | 13 | $405 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $380 | None |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $374 | $31 |
Drugs they prescribed that Part D paid
$2,096
Pharmacies billed $2,096 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 66% of their Part D prescriptions (81 of 123) in 2024. A higher opioid share than 9 in 10 peers; the typical orthopedic surgery clinician is at 31%.
123 generic and 0 brand-name prescriptions · $2,096 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone-Acetaminophen | 26 | $392 | $10 |
| Hydrocodone-Acetaminophen | 30 | $274 | $8 |
Year by year
| 2024 | 123 | 69 | 66% (81) | 0% | $2,096 |
| 2023 | 117 | 60 | 69% (81) | None | $1,563 |
| 2022 | 104 | 66 | 72% (75) | 0% | $1,100 |
| 2021 | 90 | 48 | 53% (48) | None | $1,594 |
| 2020 | 96 | 51 | 57% (55) | None | $1,792 |
| 2019 | 79 | 44 | 76% (60) | 0% | $790 |
| 2018 | 89 | 51 | 73% (65) | 0% | $828 |
| 2017 | 141 | 71 | 59% (83) | None | $2,222 |
| 2016 | 132 | 65 | 72% (95) | None | $2,918 |
| 2015 | 171 | 68 | 67% (115) | None | $3,549 |
| 2014 | 136 | 62 | 68% (93) | 12% | $3,834 |
| 2013 | 76 | 45 | 66% (50) | None | $3,105 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Celecoxib | 12 | $613 | $51 |
| Oxycodone-Acetaminophen | 46 | $510 | $11 |
| Hydrocodone-Acetaminophen | 22 | $192 | $9 |
2022: 2 drugs
| Oxycodone-Acetaminophen | 39 | $502 | $13 |
| Hydrocodone-Acetaminophen | 29 | $234 | $8 |
2021: 3 drugs
| Oxycodone-Acetaminophen | 31 | $343 | $11 |
| Ondansetron Odt | 12 | $179 | $15 |
| Hydrocodone-Acetaminophen | 14 | $171 | $12 |
2020: 2 drugs
| Oxycodone-Acetaminophen | 37 | $597 | $16 |
| Hydrocodone-Acetaminophen | 14 | $117 | $8 |
2019: 2 drugs
| Oxycodone-Acetaminophen | 34 | $501 | $15 |
| Hydrocodone-Acetaminophen | 19 | $126 | $7 |
2018: 2 drugs
| Oxycodone-Acetaminophen | 38 | $454 | $12 |
| Hydrocodone-Acetaminophen | 17 | $167 | $10 |
2017: 2 drugs
| Oxycodone-Acetaminophen | 35 | $448 | $13 |
| Hydrocodone-Acetaminophen | 29 | $275 | $9 |
2016: 3 drugs
| Oxycodone-Acetaminophen | 41 | $746 | $18 |
| Hydrocodone-Acetaminophen | 32 | $510 | $16 |
| Tramadol | 11 | $37 | $3 |
2015: 3 drugs
| Oxycodone-Acetaminophen | 52 | $1,093 | $21 |
| Hydrocodone-Acetaminophen | 47 | $723 | $15 |
| Tramadol | 13 | $32 | $2 |
2014: 3 drugs
| Xarelto | 12 | $1,563 | $130 |
| Oxycodone-Acetaminophen | 37 | $896 | $24 |
| Hydrocodone-Acetaminophen | 43 | $545 | $13 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 33 | $566 | $17 |
Money from drug and device companies
$805 in 2025
| 2025 | 3 | 3 | None | $805 |
| 2024 | 3 | 4 | None | $165 |
| 2023 | 5 | 15 | None | $1,627 |
| 2022 | 3 | 8 | $148 | $182 |
| 2021 | 2 | 28 | $677 | $725 |
| 2020 | 2 | 22 | $267 | $286 |
| 2019 | 2 | 3 | $24 | $54 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $659 | 1 payment
|
| Evolution Surgical | None | $127 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $19 | 1 payment
|
See all 3 published payments
| Evolution Surgical | Meals · 2025-05-28 | None | $127 |
| Stryker | Travel · 2025-05-02 | Mako | $659 |
| Collegium Pharmaceutical | Meals · 2025-02-10 | Belbuca | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $165
| DePuy Synthes Sales | N/A | $110 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $31 | 2 payments
|
| Stryker | Mako | $24 | 1 payment
|
2023: $1,627
| Evolution Surgical | None | $931 | 4 payments
|
| Arthrex | None | $397 | 4 payments
|
| Stryker | Infinity | $173 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $93 | 5 payments
|
| Paragon 28 | Monkey Rings | $32 | 1 payment
|
2022: $182
| Djo | Procare | $148 | 6 payments
|
| Collegium Pharmaceutical | Xtampza | $19 | 1 payment
|
| Bioventus | Gelsyn-3 | $15 | 1 payment
|
2021: $725
| Djo | Aircast Bracing & Supports | $677 | 27 payments
|
| Globus Medical | Distal Tibia Plating | $48 | 1 payment
|
2020: $286
| Djo | None | $267 | 21 payments
|
| Ferring Pharmaceuticals | Euflexxa | $19 | 1 payment
|
2019: $54
| DePuy Synthes Sales | Monovisc | $30 | 1 payment
|
| Djo | None | $24 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114964400
- Licence
- CA G72983California G72983: Current · expires 2027-10-31
- Trained
- University of California, Davis School of Medicine, 1990
- Group
- Sutter Bay Medical Foundation · California Sports and Orthopaedic
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 350 30th St Ste 530, Oakland, CA, 94609
- NPI first listed
- 2006-06-02
- NPI last updated
- 2025-10-23
- NPI record certified
- 2025-10-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2999 Regent St Ste 225, Berkeley, CA, 94705 · 80 Grand Ave, Oakland, CA, 94612